Skip to main content

RHUMBLINE ADVISERS

Position in MLYS — Mineralys Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in MLYS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,894,130
+$337,973 QoQ
Shares Held
70,205
+22.2% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#95
of 224 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 22% Shared 0% None 78%

Common Shares in MLYS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. MLYS ranks #102 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MLYS

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,894,130 70,205
2026-03-31 $1,556,157 57,444
2025-12-31 $1,969,966 54,284
2025-09-30 $2,096,634 55,291
2025-06-30 $725,153 53,596
2025-03-31 $625,052 39,361
2024-12-31 $499,244 40,556
2024-09-30 $482,716 39,861
2024-06-30 $480,624 41,079
2024-03-31 $291,249 22,560
2023-12-31 $176,033 20,469
2023-09-30 $163,324 17,174
2023-06-30 $253,959 14,895
2023-03-31 $171,633 10,960